These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 38385191

  • 1. Potassium-competitive acid blockers: rethinking acid suppression for gastroesophageal reflux disease and Helicobacter pylori.
    Antequera CM, Orleck K, Jacob R, Kenneally A, Wright WL.
    Postgrad Med; 2024 Mar; 136(2):131-140. PubMed ID: 38385191
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Indications and consequences of Helicobacter pylori eradication on gastroesophageal reflux disease].
    Gisbert JP, Piqué JM.
    Med Clin (Barc); 2005 May 14; 124(18):697-709. PubMed ID: 15899166
    [Abstract] [Full Text] [Related]

  • 4. Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD.
    Mukaisho K, Hagiwara T, Nakayama T, Hattori T, Sugihara H.
    World J Gastroenterol; 2014 Sep 14; 20(34):11962-5. PubMed ID: 25232231
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
    Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.
    Yale J Biol Med; 1999 Sep 14; 72(2-3):211-8. PubMed ID: 10780583
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
    Teng M, Khoo AL, Zhao YJ, Lin L, Lim BP, Wu TS, Dan YY.
    J Clin Pharm Ther; 2015 Aug 14; 40(4):368-75. PubMed ID: 25893507
    [Abstract] [Full Text] [Related]

  • 9. Drugs, bugs, and esophageal pH profiles.
    Robinson M.
    Yale J Biol Med; 1999 Aug 14; 72(2-3):169-72. PubMed ID: 10780578
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP, Pajares JM, Losa C.
    Hepatogastroenterology; 1999 Aug 14; 46(26):1023-9. PubMed ID: 10370661
    [Abstract] [Full Text] [Related]

  • 12. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.
    Kirchheiner J, Glatt S, Fuhr U, Klotz U, Meineke I, Seufferlein T, Brockmöller J.
    Eur J Clin Pharmacol; 2009 Jan 14; 65(1):19-31. PubMed ID: 18925391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Novel approaches to inhibition of gastric acid secretion.
    Sachs G, Shin JM, Hunt R.
    Curr Gastroenterol Rep; 2010 Dec 14; 12(6):437-47. PubMed ID: 20924727
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of Acid-related Diseases Using Potassium-competitive Acid Blockers].
    Choi YJ.
    Korean J Gastroenterol; 2022 Dec 25; 80(6):247-253. PubMed ID: 36567437
    [Abstract] [Full Text] [Related]

  • 18. Predictors and timing for the development of symptomatic gastroesophageal reflux disease after successful Helicobactor pylori eradication therapy.
    Shinozaki S, Osawa H, Hayashi Y, Miura Y, Yano T, Lefor AK, Yamamoto H.
    Scand J Gastroenterol; 2022 Jan 25; 57(1):16-21. PubMed ID: 34547219
    [Abstract] [Full Text] [Related]

  • 19. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.
    Yang X, Li Y, Sun Y, Zhang M, Guo C, Mirza IA, Li YQ.
    Dig Dis Sci; 2018 Feb 25; 63(2):302-311. PubMed ID: 29282636
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.